Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001171520-15-000016
Filing Date
2015-01-07
Accepted
2015-01-06 18:38:53
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS LLCRHO VENTURES V AFFILIATES, L.L.C.RHO VENTURES V, L.P.RMV V, L.L.C.

Document Format Files

Seq Description Document Type Size
1 eps6010.htm SC 13D/A 162031
  Complete submission text file 0001171520-15-000016.txt   164041
Mailing Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019
Business Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures V, L.P. (Filed by) CIK: 0001325383 (see all company filings)

EIN.: 201953730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Subject) CIK: 0001338095 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88014 | Film No.: 15511574
SIC: 2834 Pharmaceutical Preparations